Podocyte number in normotensive type 1 diabetic patients with albuminuria.
about
Using stereologic techniques for podocyte counting in the mouse: shifting the paradigmPodometrics as a Potential Clinical Tool for Glomerular Disease ManagementMorphologic features of declining renal function in type 1 diabetesPodocyte pathology and nephropathy - sphingolipids in glomerular diseasesMolecular mechanisms of diabetic kidney diseaseDysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional studyClinical therapeutic strategies for early stage of diabetic kidney disease.Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury.Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritisReduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment.Conditionally immortalized human podocyte cell lines established from urine.Mechanistic connection between inflammation and fibrosisNormoglycemic diabetic nephropathy: the role of insulin resistance.Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion.Genipin inhibits mitochondrial uncoupling protein 2 expression and ameliorates podocyte injury in diabetic mice.Podocyte number in the maturing rat kidneyCyclin I protects podocytes from apoptosis.Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytesMessenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathyPathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivoMicrovascular basement membranes in diabetes mellitus.Lipid biology of the podocyte--new perspectives offer new opportunities.Insulin signaling: implications for podocyte biology in diabetic kidney disease.Recent advances in diabetic nephropathyPodocyte hypertrophy precedes apoptosis under experimental diabetic conditions.Urine podocyte mRNAs mark disease activity in IgA nephropathy.Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy.Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients.CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.Dendrin ablation prolongs life span by delaying kidney failure.Diet-Induced Podocyte Dysfunction in Drosophila and Mammals.Podocyte Number in Children and Adults: Associations with Glomerular Size and Numbers of Other Glomerular Resident CellsPodocyte Depletion in Thin GBM and Alport Syndrome.Growth-dependent podocyte failure causes glomerulosclerosis.Emerging role of autophagy in kidney function, diseases and agingThe podocyte: from bench to bedside.Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker
P2860
Q24608048-E558461E-0B58-4278-B336-7C15D454A43AQ26799182-CFF95B90-46D2-4FCC-ABEB-D090C1088C6AQ26852459-4A1253CA-4EC6-4953-A557-7A29E5C2BE1DQ26852463-36BDA4BE-A289-435F-8AD6-5132ED9180F0Q27003963-B0BA8BE4-AAA7-43E5-8B28-39E9DE9261BDQ28729900-E588C184-675D-4FC0-8B31-4A2A2426593DQ30363683-C69EE473-B08C-409C-87BA-A0178ABE40B7Q30581831-E1988004-F5AC-455B-9362-4A27C2D28CFDQ30999305-1674C580-616F-4232-9F8D-59F50BEF9A88Q33236615-79D76E63-3DB3-4902-9D6B-94D9518CB7CDQ33727877-E6ACD6F5-0112-4119-BDDB-FA7F22387C3DQ33792541-B24C3BBA-DE9E-4492-8E4F-793276297CA7Q33935871-97D3238A-C857-4B50-B44E-057F74D64DFEQ34229974-D9AB21BB-19BA-4C54-801A-424C7C210544Q34358426-37C69A3B-F65C-442F-93C9-0EC687569EC0Q34537769-793A2732-50DB-4991-A641-C93E23C9340FQ34569176-C1135874-CE40-44E5-84CC-7F741CBEBD79Q34787780-C5583035-F02A-4872-A2F3-60903C1CB589Q34801482-A01CE57F-9383-4552-8890-5D2F6E0CFC80Q35011234-795822DD-8FC9-4AB3-9B92-710CE5BC0238Q35070778-F5B75281-0CB5-437F-AB97-D59FE39C7CF0Q35135695-8A7FB47F-5364-4096-9572-F78607371E3FQ35170462-C44EB114-6AD6-44F7-87F5-5EAF3DED5D81Q35285568-7B231652-4A3C-4B6C-A0B3-B8D89E9940A0Q35285585-F9D8EEA5-3795-4111-AF80-F1758F977280Q35520625-7DD21E20-BC33-4A5D-B646-5AC612F8DE93Q35624799-ABB01610-1D62-4B8A-8670-141B93F8DA1EQ35777614-175395DA-AD0B-41DF-9245-35A1C164F2C2Q35844164-00017BEF-A5AB-4C57-AE54-9BB56C75B415Q35888006-D778ADF3-2076-49D2-AC2B-6424EF154B6DQ35893390-F1B34438-04B9-418D-9761-08B4A3601E17Q35931836-520B912D-1ACF-459B-AA40-78C3576A97B8Q35941157-C542FCA8-35DA-4E11-8687-3D0D087B48BEQ36003114-8004257C-F3BC-41E6-9C4C-5A7834757203Q36021415-0FF016C7-8040-40F8-AF86-23105A5ECD4BQ36109205-676D5259-EF4A-4BF0-98D3-1BF62A1E6DEEQ36194753-9BE278D2-501A-4357-9173-58B5E07484DFQ36219510-5DC5B0B2-DADD-450A-8ADB-EC69000A0293Q36314908-15D7C925-3379-42BD-9132-90E35F76ABA7Q36389219-F77FA7D9-CF05-48EA-B899-702F8FF43482
P2860
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
@en
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
@nl
type
label
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
@en
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
@nl
prefLabel
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
@en
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
@nl
P2093
P1433
P1476
Podocyte number in normotensive type 1 diabetic patients with albuminuria.
@en
P2093
Giampiero Piras
GianCarlo Viberti
Kathryn E White
Meguid El Nahas
Rudolf W Bilous
Sally M Marshall
P304
P356
10.2337/DIABETES.51.10.3083
P407
P577
2002-10-01T00:00:00Z